/ Biochip News November 8, 2004 Edition
from EMX Corporation (New York and London) is the basis of a new line of cellular phones from
Ghanz EMF Telecom (New York). Reports indicate
that the use of the radiation-free cellular phones will reduce the odds for the development of cell abnormalities related
to cancer. The technology is expected to be applied to other electronic devices.
reported that it will expand its products to include absolute pressure sensors for health and safety applications. The absolute pressure sensors are based on 3D MEMs technology.
Inc. has reported production delays for its biochips. The company has in development biochips to isolate DNAs and
proteins for testing. Pilot production is expected to commence in early 2005.
Technologies has announced that it has sold over 1 million Labchips.
For the nine months ended September 30, 2004 Caliper Life Sciences, Inc.
reported revenues increased two fold from $28.0 million to $56.0 million. Product revenue increased from $18.3 million to
$39.8 million. Service revenue increased nearly five fold to $10.1 million.